Previous studies have shown that THD can upregulate the expression of NRP-1 and increase the number of Tregs in ITP patients, and induce response in corticosteroid-resistant or recurrent ITP patients (8). Here, NRP1 is linked to autoimmune thrombocytopenic purpura.